7.32
+0.125(+1.74%)
Currency In USD
| Previous Close | 7.19 |
| Open | 7.28 |
| Day High | 7.4 |
| Day Low | 7.11 |
| 52-Week High | 16.74 |
| 52-Week Low | 5.28 |
| Volume | 4.09M |
| Average Volume | 1.94M |
| Market Cap | 1.16B |
| PE | -9.14 |
| EPS | -0.8 |
| Moving Average 50 Days | 8.14 |
| Moving Average 200 Days | 8.68 |
| Change | 0.13 |
If you invested $1000 in Wave Life Sciences Ltd. (WVE) since IPO date, it would be worth $457.19 as of October 08, 2025 at a share price of $7.315. Whereas If you bought $1000 worth of Wave Life Sciences Ltd. (WVE) shares 5 years ago, it would be worth $810.98 as of October 08, 2025 at a share price of $7.315.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
GlobeNewswire Inc.
Sep 18, 2025 12:30 PM GMT
CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that it will hos
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
GlobeNewswire Inc.
Sep 03, 2025 11:30 AM GMT
Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 µM total AAT, 7.2 µM M-AAT) First-ever demonstration of therapeutically restored p
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025
GlobeNewswire Inc.
Jul 23, 2025 12:30 PM GMT
CAMBRIDGE, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conf